Point72 Asset Management, L.P. 13D/13G Filings for Avalo Therapeutics, Inc. (AVTX)

Point72 Asset Management, L.P. 13D and 13G filings for Avalo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
4:29 pm
Purchase		 2021-12-31 13G Avalo Therapeutics, Inc.
AVTX		 Point72 Asset Management, L.P. 2,088
5.400%		 1increase
(+0.05%)		 Filing
2021-09-21
4:51 pm
Purchase		 2021-09-17 13G Avalo Therapeutics, Inc.
AVTX		 Point72 Asset Management, L.P. 2,087
5.400%		 2,087increase
(New Position)		 Filing